Category archives: Generics

Can You Get the Coronavirus Twice?

Can You Get the Coronavirus Twice?
?There is probably an interaction between age, between gender, and between underlying diseases that determines how you respond to this virus.? We don?t know whether the presence of antibodies guarantees a person is protected from reinfection

The Controversy Over Chloroquine for COVID-19

The Controversy Over Chloroquine for COVID-19
An old drug is getting new attention, but is it for the right reasons? In regular press briefings on COVID-19, President Trump and members of his administration have repeatedly touted a potential treatment: hydroxychloroquine. On Twitter the president described it as potentially ?one of the biggest game changers in the history of medicine.? However Dr. Anthony Fauci, director of the National Institute of Allergy and Infectious Diseases (NIAID) and prominent member of the coronavirus task force, has tried to temper enthusiasm for the therapeutic regimen, citing a lack of evidence. So what?s driving the hype around this old drug, and is it deserved?

It might be difficult to implement compulsory prescription of generics

It might be difficult to implement compulsory prescription of generics
The enforcement by the drug regulator will not be easy given the shortage of drug inspectors {Taj Life Sciences} Generic Drug Division} Prime Minister Narendra Modi wants to defeat the doctor-pharmaceutical company nexus and make medicines affordable by making it compulsory to prescribe drugs in the generic name. But, the...

Despite lower price of generic imatinib, overall costs for chronic myeloid leukemia remain high

Despite lower price of generic imatinib, overall costs for chronic myeloid leukemia remain high
Despite lower price of generic imatinib, overall costs for chronic myeloid leukemia remain high ORLANDO ? The price of generic imatinib has decreased substantially in the United States over the past 2 years, according to a speaker at ASH Annual Meeting and Exposition. The decline comes after steep increases in...

{Taj Life Sciences}: Women’s Healthcare Awareness Initiative

{Taj Life Sciences}: Women’s Healthcare Awareness Initiative
Women?s Poor health condition in India: There?s lack of awareness about women?s health in India, mostly due to the taboos and superstitions associated with female genital hygiene and menstruation. Every 8 minutes, an Indian woman dies due to cervical cancer. Statistics state that this is the second-most common cancer among...

Another Record Year for Generic Drug Approvals {Taj Life Sciences}: [Generic Competition]

Another Record Year for Generic Drug Approvals {Taj Life Sciences}: [Generic Competition]
Another Record Year for Generic Drug Approvals {Taj Life Sciences}: [Generic Competition] For each of the last five years, the US Food and Drug Administration (FDA) has set generic drug approval records, but questions have lingered on whether these high approval numbers are translating into competition. FY 2019 figures show...

Look back at the decade: Generic drugs

Look back at the decade: Generic drugs
Fifteen years after it rose and went limp, the biotech sector saw a bull run of sorts In 2010, an unusual protest erupted over a still negotiated and secret free trade agreement between India and the European Union. Protesters were people living with HIV/AIDS and cancer. They saw a threat...